Columbia Laboratories

According to Benchmark, Columbia Laboratories (NASDAQ: CBRX) favorable results in pregnant study were published in the journal Ultrasound in Obstetrics and Gynecology. Benchmark reported that data shows treatment with Columbia's Prochieve reduced incidence of preterm birth 45% compared with...